Magnetic resonance imaging applications on infiltrative cardiomyopathies

Journal of Thoracic Imaging

Volumn 31, Issue 6, 2016, Pages 336-347

  Muehlberg, Fabian ^a,b   Toepper, Agnieszka ^a,b   Fritschi, Simone ^a,b   Prothmann, Marcel ^a,b   Schulz Menger, Jeanette ^a,b,c  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b Helios Hospital Berlin Buch   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

cardiomyopathies; cardiovascular magnetic resonance; infiltrative cardiomyopathies; noninvasive imaging

Indexed keywords

GADOLINIUM;

AMYLOIDOSIS; CARCINOID; CARDIAC IMAGING; CARDIAC MAPPING SYSTEM; CARDIAC MUSCLE; CARDIOMYOPATHY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; EDEMA; FABRY DISEASE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART VOLUME; HEMOCHROMATOSIS; HYPEREMIA; INFILTRATIVE CARDIOMYOPATHY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION INJURY; SYSTEMIC SCLEROSIS; DIAGNOSTIC IMAGING; HEART; HUMAN; PROCEDURES;

CARDIOMYOPATHIES; HEART; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84961392714     PISSN: 08835993     EISSN: 15360237     Source Type: Journal    
DOI: 10.1097/RTI.0000000000000199     Document Type: Conference Paper

References (81)

1. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008; 29: 270-276
2. Modell B, Khan M, Darlison M, et al. Improved survival of thalassaemia major in the UK and relation to T2∗ cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008; 10: 42
3. Friedrich MG, Bucciarelli-Ducci C, White JA, et al. Simplifying cardiovascular magnetic resonance pulse sequence terminology. J Cardiovasc Magn Reson. 2014; 16: 3960
4. Kellman P, Chefdhotel C, Lorenz CH, et al. Fully automatic, retrospective enhancement of real-time acquired cardiac cine MR images using image-based navigators and respiratory motion-corrected averaging. Magn Reson Med. 2008; 59: 771-778
5. De Cobelli F, Pieroni M, Esposito A, et al. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol. 2006; 47: 1649-1654
6. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001; 218: 215-223
7. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005; 45: 1815-1822
8. Ferreira VM, Piechnik SK, DallArmellina E, et al. Noncontrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012; 14: 42
9. Wassmuth R, Prothmann M, Utz W, et al. Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema. J Cardiovasc Magn Reson. 2013; 15: 27
10. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation. 1998; 97: 1802-1809
11. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 343: 1445-1453
12. Wu E, Judd RM, Vargas JD, et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Qwave myocardial infarction. Lancet. 2001; 357: 21-28
13. Syed IS, Glockner JF, Feng D, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging. 2010; 3: 155-164
14. Kellman P, Arai AE, McVeigh ER, et al. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002; 4: 372-383
15. Nguyen TD, Spincemaille P, Weinsaft JW, et al. A fast navigator-gated 3D sequence for delayed enhancement MRI of the myocardium: comparison with breathhold 2D imaging. J Magn Reson Imaging. 2008; 27: 802-808
16. Messroghli DR, Radjenovic A, Kozerke S, et al. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004; 52: 141-146
17. Piechnik SK, Ferreira VM, Dall Armellina E, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010; 12: 69
18. Kawel N, Nacif M, Zavodni A, et al. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson. 2012; 14: 26
19. Verhaert D, Thavendiranathan P, Giri S, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging. 2011; 4: 269-278
20. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2∗ ) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001; 22: 2171-2179
21. Meloni A, Positano V, Ruffo GB, et al. Improvement of heart iron with preserved patterns of iron store by CMR-guided chelation therapy. Eur Heart J Cardiovasc Imaging. 2015; 16: 325-334
22. Foll D, Jung B, Schilli E, et al. Magnetic resonance tissue phase mapping of myocardial motion: new insight in age and gender. Circ Cardiovasc Imaging. 2010; 3: 54-64
23. Rider OJ, Ajufo E, Ali MK, et al. Myocardial tissue phase mapping reveals impaired myocardial tissue velocities in obesity. Int J Cardiovasc Imaging. 2015; 31: 339-347
24. Heyne JP, Rzanny R, Hansch A, et al. 31P-MR spectroscopic imaging in hypertensive heart disease. Eur Radiol. 2006; 16: 1796-1802
25. McGill LA, Ismail TF, Nielles-Vallespin S, et al. Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2012; 14: 86
26. Austin BA, Tang WH, Rodriguez ER, et al. Delayed hyperenhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging. 2009; 2: 1369-1377
27. Pozo E, Kanwar A, Deochand R, et al. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis. Heart. 2014; 100: 1688-1695
28. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005; 111: 186-193
29. Perugini E, Rapezzi C, Piva T, et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart. 2006; 92: 343-349
30. Rudolph A, Abdel-Aty H, Bohl S, et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol. 2009; 53: 284-291
31. Maceira AM, Prasad SK, Hawkins PN, et al. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson. 2008; 10: 54
32. Banypersad SM, Fontana M, Maestrini V, et al. T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J. 2015; 36: 244-251
33. Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013; 6: 488-497
34. Banypersad SM, Sado DM, Flett AS, et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging. 2013; 6: 34-39
35. Wassmuth R, Abdel-Aty H, Bohl S, et al. Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis. Eur Radiol. 2011; 21: 1643-1650
36. Sheppard MN, Cane P, Florio R, et al. A detailed pathologic examination of heart tissue from three older patients with Anderson-Fabry disease on enzyme replacement therapy. Cardiovasc Pathol. 2010; 19: 293-301
37. Sado DM, Flett AS, Banypersad SM, et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart. 2012; 98: 1436-1441
38. De Cobelli F, Esposito A, Belloni E, et al. Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. AJR Am J Roentgenol. 2009; 192: W97-102
39. Pica S, Sado DM, Maestrini V, et al. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2014; 16: 99
40. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med. 2005; 118: 2-10
41. Fernandes F, Ramires FJ, Arteaga E, et al. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail. 2003; 9: 311-317
42. Ntusi NA, Piechnik SK, Francis JM, et al. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis - A clinical study using myocardial T1-mapping and extracellular volume quantification. J Cardiovasc Magn Reson. 2014; 16: 21
43. Allanore Y, Meune C, Vonk MC, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis. 2010; 69: 218-221
44. Bezante GP, Rollando D, Sessarego M, et al. Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis. J Rheumatol. 2007; 34: 2431-2437
45. Hachulla AL, Launay D, Gaxotte V, et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis. 2009; 68: 1878-1884
46. Sano M, Satoh H, Suwa K, et al. Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis. Heart Vessels. 2014; 6: 779-788
47. Rodriguez-Reyna TS, Morelos-Guzman M, Hernandez-Reyes P, et al. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography. Rheumatology (Oxford). 2015; 54: 647-654
48. Di Cesare E, Battisti S, Di Sibio A, et al. Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CEMRI). Eur J Radiol. 2013; 82: e268-e273
49. Pieroni M, De Santis M, Zizzo G, et al. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum. 2014; 43: 526-535
50. Thuny F, Lovric D, Schnell F, et al. Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis. Radiology. 2014; 271: 373-380
51. Barison A, Gargani L, De Marchi D, et al. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. 2015; 16: 74-80
52. Wayengera M. Searching for new clues about the molecular cause of endomyocardial fibrosis by way of in silico proteomics and analytical chemistry. PLoS One. 2009; 4: e7420
53. Mocumbi AO, Carrilho C, Burke MM, et al. Emergency surgical treatment of advanced endomyocardial fibrosis in Mozambique. Nat Clin Pract Cardiovasc Med. 2009; 6: 210-214
54. Qureshi N, Amin F, Chatterjee D, et al. MR imaging of endomyocardial fibrosis (EMF). Int J Cardiol. 2011; 149: e36-e37
55. Jariwala N, McGraw S, Rangarajan VS, et al. The V sign of endomyocardial fibrosis. QJM. 2014; 5: 423-424
56. Schneeweis C, Berger A, Kelle S, et al. Endomyocardial fibrosis in patients with confirmed Churg-Strauss syndrome. Rheumatology (Oxford). 2014; 53: 84
57. Ramage JK, Ahmed A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut. 2012; 61: 6-32
58. Grozinsky-Glasberg S, Grossman AB, Gross DJ. Carcinoid heart disease: from pathophysiology to treatment-Something in the Way It Moves. Neuroendocrinology. 2015; 4: 263-273
59. Klobucic M, Paar MH, Padovan RS, et al. New images in carcinoid heart disease. Cardiovasc J Afr. 2012; 23: e8-10
60. Bardou-Jacquet E, Ben Ali Z, Beaumont-Epinette MP, et al. Non-HFE hemochromatosis: pathophysiological and diagnostic aspects. Clin Res Hepatol Gastroenterol. 2014; 38: 143-154
61. Tanner MA, Galanello R, Dessi C, et al. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation. 2007; 115: 1876-1884
62. Pennell DJ, Udelson JE, Arai AE, et al. Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013; 128: 281-308
63. Westwood M, Anderson LJ, Firmin DN, et al. A single breathhold multiecho T2∗ cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging. 2003; 18: 33-39
64. Kirk P, Roughton M, Porter JB, et al. Cardiac T2∗ magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009; 120: 1961-1968
65. He T, Gatehouse PD, Kirk P, et al. Black-blood T2∗ technique for myocardial iron measurement in thalassemia. J Magn Reson Imaging. 2007; 25: 1205-1209
66. Carpenter JP, He T, Kirk P, et al. On T2∗ magnetic resonance and cardiac iron. Circulation. 2011; 123: 1519-1528
67. Tanner MA, He T, Westwood MA, et al. Multi-center validation of the transferability of the magnetic resonance T2∗ technique for the quantification of tissue iron. Haematologica. 2006; 91: 1388-1391
68. Storey P, Thompson AA, Carqueville CL, et al. R2∗ imaging of transfusional iron burden at 3T and comparison with 1.5T. J Magn Reson Imaging. 2007; 25: 540-547
69. Ghugre NR, Doyle EK, Storey P, et al. Relaxivity-iron calibration in hepatic iron overload: Predictions of a Monte Carlo model. Magn Reson Med. 2014; 3: 879-883
70. Plana JC. Added value of real-time three-dimensional echocardiography in assessing cardiac masses. Curr Cardiol Rep. 2009; 11: 205-209
71. American College of Cardiology Foundation Task Force on Expert Consensus Documents, Hundley WG, Bluemke DA, Finn JP, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010; 55: 2614-2662
72. Hoffmann U, Globits S, Schima W, et al. Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. Am J Cardiol. 2003; 92: 890-895
73. Roberts WC. Primary and secondary neoplasms of the heart. Am J Cardiol. 1997; 80: 671-682
74. Araoz PA, Mulvagh SL, Tazelaar HD, et al. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics. 2000; 20: 1303-1319
75. Abraham KP, Reddy V, Gattuso P. Neoplasms metastatic to the heart: review of 3314 consecutive autopsies. Am J Cardiovasc Pathol. 1990; 3: 195-198
76. Ylanen K, Eerola A, Vettenranta K, et al. Three-dimensional echocardiography and cardiac magnetic resonance imaging in the screening of long-term survivors of childhood cancer after cardiotoxic therapy. Am J Cardiol. 2014; 113: 1886-1892
77. Heck SL, Gulati G, Ree AH, et al. Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial. Cardiology. 2012; 123: 240-247
78. Bruder O, Wagner A, Lombardi M, et al. European Cardiovascular Magnetic Resonance (EuroCMR) registry-multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson. 2013; 15: 9
79. Kramer CM, Barkhausen J, Flamm SD, et al. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013; 15: 91
80. Schulz-Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013; 15: 35
81. Muehlberg F, Neumann D, von Knobelsdorff-Brenkenhoff F, et al. A multicenter cardiovascular MR network for teletraining and beyond: setup and initial experiences. J Am Coll Radiol. 2015; 12: 876-883